Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

61230

registered interest
date	10/06/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Cancer: Drugs
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what assessment they have made of the impact of the proposals for value-based assessments published by the National Institute for Healthand Care Excellence on 22 March 2014 on patients' access to new cancer medicines.
tabling member printed	Lord Walton of Detchant
uin	HL190
answer	answer is ministerial correction date of answer 16/06/2014 answer text <p>A consultation on the National Institute for Health and Care Excellence's (NICE) proposals for value assessment is ongoing and no decisions have yet been made about any potential changes to NICE's methods of technology appraisal.</p><p> </p><p>The consultation will close on 20 June and we would encourage all those with an interest, including patients, clinicians, the National Health Service, industry, researchers and academic experts, to make their views known as part of this process.</p><p> </p> answering member printed Earl Howe grouped question UIN HL191 question first answered 16/06/2014 11:27:57 answering member 2000 label Biography information for Earl Howe
tabling member	1716 label Biography information for Lord Walton of Detchant

61231

registered interest
date	10/06/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Cancer: Drugs
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what effect the new proposals for value-based assessments published by the National Institute for Healthand Care Excellence on 22 March 2014 have had on the availability of treatments to patients with (1) those forms of cancer which are more frequent in older people, and (2) rare types of cancer.
tabling member printed	Lord Walton of Detchant
uin	HL191
answer	answer is ministerial correction date of answer 16/06/2014 answer text <p>A consultation on the National Institute for Health and Care Excellence's (NICE) proposals for value assessment is ongoing and no decisions have yet been made about any potential changes to NICE's methods of technology appraisal.</p><p> </p><p>The consultation will close on 20 June and we would encourage all those with an interest, including patients, clinicians, the National Health Service, industry, researchers and academic experts, to make their views known as part of this process.</p><p> </p> answering member printed Earl Howe grouped question UIN HL190 question first answered 16/06/2014 11:27:57 answering member 2000 label Biography information for Earl Howe
tabling member	1716 label Biography information for Lord Walton of Detchant

60548

registered interest
date	09/06/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Minor Injuries Units: Cannock Chase
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what action they are taking in respect of the proposed reduction in service at the Cannock Chase Minor Injuries Unit.
tabling member printed	Lord Hunt of Kings Heath
uin	HL137
answer	answer is ministerial correction date of answer 16/06/2014 answer text <p>The reconfiguration of local health services is a matter for the National Health Service. All service changes should be led by clinicians and be in the best interests of patients, not driven from the top down.</p><p> </p><p>We are aware that local general practitioners in Cannock Chase Clinical Commissioning Group are currently developing proposals for the future configuration of the Cannock Chase Minor Injuries Unit. Any proposed service redesign would be subject to public consultation in due course. No decisions on the future of the unit have been made yet.</p> answering member printed Earl Howe grouped question UIN HL138 question first answered 16/06/2014 11:34:46 answering member 2000 label Biography information for Earl Howe
tabling member	2024 label Biography information for Lord Hunt of Kings Heath

60549

registered interest
date	09/06/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Minor Injuries Units: Cannock Chase
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what assessment they have made of the impact of the changes to service provision at the Cannock Chase Minor Injuries Unit onemergency departments in Staffordshire and Wolverhampton.
tabling member printed	Lord Hunt of Kings Heath
uin	HL138
answer	answer is ministerial correction date of answer 16/06/2014 answer text <p>The reconfiguration of local health services is a matter for the National Health Service. All service changes should be led by clinicians and be in the best interests of patients, not driven from the top down.</p><p> </p><p>We are aware that local general practitioners in Cannock Chase Clinical Commissioning Group are currently developing proposals for the future configuration of the Cannock Chase Minor Injuries Unit. Any proposed service redesign would be subject to public consultation in due course. No decisions on the future of the unit have been made yet.</p> answering member printed Earl Howe grouped question UIN HL137 question first answered 16/06/2014 11:34:45 answering member 2000 label Biography information for Earl Howe
tabling member	2024 label Biography information for Lord Hunt of Kings Heath

60586

registered interest
date	09/06/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Levodopa
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what steps they are taking to ensure that clinicians making Individual Funding Requestsfor the prescription of Duodopa to people with Parkinson's are informed of the outcome within 40 days.
tabling member printed	Baroness Gale
uin	HL175
answer	answer is ministerial correction date of answer 16/06/2014 answer text <p>From April 2013, NHS England assumed responsibility for commissioning adult specialist neurosciences services, including the majority of services for patients with Parkinson's disease, with some being the responsibility of clinical commissioning groups.</p><p> </p><p>NHS England has advised that it does not routinely fund Duodopa (co-careldopa) for the treatment of Parkinson's disease. Clinicians can submit individual funding requests for this treatment on behalf of their patients as per NHS England's individual funding requests standard operating procedure, which is at:</p><p> </p><p>www.england.nhs.uk/wp-content/uploads/2013/04/cp-04.pdf</p><p> </p><p>NHS England has advised that its individual funding request process is monitored against the standard operating procedure to ensure that referring clinicians are informed of outcomes in a timely manner.</p> answering member printed Earl Howe question first answered 16/06/2014 11:30:46 answering member 2000 label Biography information for Earl Howe
tabling member	2503 label Biography information for Baroness Gale

60587

registered interest
date	09/06/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Levodopa
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what steps they are taking to ensure that recommendations by the Clinical Priorities Advisory Group on theprescription of Duodopa for people with Parkinson's have been developed with public and patient engagement.
tabling member printed	Baroness Gale
uin	HL176
answer	answer is ministerial correction date of answer 16/06/2014 answer text <p>The operation of the Clinical Priorities Advisory Group (CPAG) is a matter for NHS England. NHS England has advised that the CPAG is chaired by a lay member and has four public members as part of its core membership.</p><p> </p><p>The draft policy on Duodopa was developed by the Neurosciences Clinical Reference Group, which has four patient/carer members. Registered patient and public stakeholders had an opportunity to share their views and comment on this draft policy before it was considered by CPAG.</p><p> </p><p>CPAG has made recommendations to NHS England. NHS England's decision on whether Duodopa should be routinely commissioned will be subject to 12 weeks public consultation.</p> answering member printed Earl Howe question first answered 16/06/2014 11:29:59 answering member 2000 label Biography information for Earl Howe
tabling member	2503 label Biography information for Baroness Gale

60590

registered interest
date	09/06/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Dentistry
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what progress they have made in preventing a shortfall of dental foundation training places from occurring in 2014 and in ensuring that positions will be found for final year students who have yet to be allocated a place.
tabling member printed	Lord Colwyn
uin	HL179
answer	answer is ministerial correction date of answer 16/06/2014 answer text <p>Health Education England (HEE) are funding more training places than the number of students forecast to graduate from dental schools in England, Wales and Northern Ireland in the 2014 recruitment. London Shared Services is leading the recruitment process on behalf of HEE for the Dental Foundation Training programme and they are currently half way through this process.</p><p> </p><p>HEE have said that more places will become available as a result of students who have accepted posts and are now deferring or have failed their final examinations.</p> answering member printed Earl Howe question first answered 16/06/2014 11:29:08 answering member 2000 label Biography information for Earl Howe
tabling member	3394 label Biography information for Lord Colwyn

60591

registered interest
date	09/06/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Dentistry
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what assessment they have made of the impact that the proposed reduction in the salaries of dental foundation trainees will have on the financial circumstances of young dentists.
tabling member printed	Lord Colwyn
uin	HL180
answer	answer is ministerial correction date of answer 16/06/2014 answer text <p>The Department is still considering the responses received to the recent consultation on the dental foundation trainee salary. One of the factors the Department will take into consideration will be the impact the proposed change will have on the financial circumstances of trainee dentists.</p> answering member printed Earl Howe question first answered 16/06/2014 11:28:25 answering member 2000 label Biography information for Earl Howe
tabling member	3394 label Biography information for Lord Colwyn

60646

registered interest
date	09/06/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Cystic Fibrosis
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps he is taking to ensure that high-cost drugs are delivered to cystic fibrosis patients on time.
tabling member constituency	Colne Valley
tabling member printed	Jason McCartney
uin	199708
answer	answer is ministerial correction date of answer 16/06/2014 answer text <p>It is important that patients, including those with cystic fibrosis, get those high cost drugs provided through homecare services on time.</p><p> </p><p>The Department commissioned a review of homecare medicine supply arrangements to ensure they deliver the best value for patients, the National Health Service and the provider market. The review report, <em>Homecare Medicines: </em><em>Towards a Vision for the Future,</em> was published in December 2011 and is available at:</p><p> </p><p>http://media.dh.gov.uk/network/121/files/2011/12/111201-Homecare-Medicines-Towards-a-Vision-for-the-Future2.pdf</p><p> </p><p>The outcome of subsequent improvement work is summarised in the further report, <em>Homecare Medicines: Towards a Vision for the Future - Taking Forward the Recommendations</em>, published in May 2014 and available at:</p><p> </p><p>www.uhns.nhs.uk/AboutUs/NHSHomecareMedicinesinEngland.aspx</p><p> </p><p>NHS England issued a patient safety alert on minimising the risks of omitted and delayed medicines for patients receiving homecare services on 10 April 2014. This recommended that all healthcare organisations that commission clinical homecare services:</p><p>- establish if medicine homecare services were used by their organisation and if incidents of omitted and delayed medicines had occurred;</p><p>- consider whether immediate action needed to be taken locally and, if required, develop an action plan, to reduce risk and the potential risk to patients;</p><p>- disseminate the alert to all medical, nursing, pharmacy and other staff involved in the care of homecare patients; and</p><p>- report patient safety incidents concerning homecare to the National Reporting and Learning Service.</p><p> </p><p>A copy of the patient safety alert is available at:</p><p> </p><p>www.england.nhs.uk/wp-content/uploads/2014/04/psa-omitted-delayed-meds.pdf</p><p> </p><p>The Department continues to work with NHS England, homecare companies, pharmaceutical suppliers and the NHS to ensure that homecare arrangements are safe and deliver value for the NHS and improved outcomes for patients.</p><p> </p> answering member constituency Central Suffolk and North Ipswich answering member printed Dr Daniel Poulter grouped question UIN 199709 question first answered 16/06/2014 13:15:27 answering member 3932 label Biography information for Dr Dan Poulter
tabling member	3953 label Biography information for Jason McCartney

60647

registered interest
date	09/06/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Home Care Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what recent assessment he has made of the effectiveness of the commissioning of homecare services by the NHS.
tabling member constituency	Colne Valley
tabling member printed	Jason McCartney
uin	199709
answer	answer is ministerial correction date of answer 16/06/2014 answer text <p>It is important that patients, including those with cystic fibrosis, get those high cost drugs provided through homecare services on time.</p><p> </p><p>The Department commissioned a review of homecare medicine supply arrangements to ensure they deliver the best value for patients, the National Health Service and the provider market. The review report, <em>Homecare Medicines: </em><em>Towards a Vision for the Future,</em> was published in December 2011 and is available at:</p><p> </p><p>http://media.dh.gov.uk/network/121/files/2011/12/111201-Homecare-Medicines-Towards-a-Vision-for-the-Future2.pdf</p><p> </p><p>The outcome of subsequent improvement work is summarised in the further report, <em>Homecare Medicines: Towards a Vision for the Future - Taking Forward the Recommendations</em>, published in May 2014 and available at:</p><p> </p><p>www.uhns.nhs.uk/AboutUs/NHSHomecareMedicinesinEngland.aspx</p><p> </p><p>NHS England issued a patient safety alert on minimising the risks of omitted and delayed medicines for patients receiving homecare services on 10 April 2014. This recommended that all healthcare organisations that commission clinical homecare services:</p><p>- establish if medicine homecare services were used by their organisation and if incidents of omitted and delayed medicines had occurred;</p><p>- consider whether immediate action needed to be taken locally and, if required, develop an action plan, to reduce risk and the potential risk to patients;</p><p>- disseminate the alert to all medical, nursing, pharmacy and other staff involved in the care of homecare patients; and</p><p>- report patient safety incidents concerning homecare to the National Reporting and Learning Service.</p><p> </p><p>A copy of the patient safety alert is available at:</p><p> </p><p>www.england.nhs.uk/wp-content/uploads/2014/04/psa-omitted-delayed-meds.pdf</p><p> </p><p>The Department continues to work with NHS England, homecare companies, pharmaceutical suppliers and the NHS to ensure that homecare arrangements are safe and deliver value for the NHS and improved outcomes for patients.</p><p> </p> answering member constituency Central Suffolk and North Ipswich answering member printed Dr Daniel Poulter grouped question UIN 199708 question first answered 16/06/2014 13:15:27 answering member 3932 label Biography information for Dr Dan Poulter
tabling member	3953 label Biography information for Jason McCartney